Zhitong Finance App News, Zhongsheng Beijing Holdings Biotechnology (08247.HK) announced that on August 5, 2026, the company (as an investor) entered into a capital increase and cooperation agreement with target companies Shanghai Jiangcun Technology Co., Ltd., Beijing Chenyimeng Technology Co., Ltd., and Ding Fang and Pan Zhenhe (shareholders of Party C and Ding Fang) to obtain a total share of about 70.3% of the target company's shares through share acquisitions and cash capital increases. The total cost of this transaction was approximately 164 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.